Eligible patients age 18 years fulfilled the Assessment of SpondyloArthritis international Society ( ASAS ) classification criteria for peripheral SpA , did not have a prior diagnosis of psoriasis , psoriatic arthritis ( PsA ) , or ankylosing spondylitis ( AS ) , and had an inadequate response or intolerance to nonsteroidal antiinflammatory drugs ( NSAIDs ) .